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ABSTRACT
WOMEN'S COMPLIANCE IN OUTPATIENT SUBSTANCE ABUSE
TREATMENT: THE ROLE OF CHILDREN AND MENTAL HEALTH
Cathy G. Cooke
Virginia Consortium Program in Clinical Psychology, 2010
Director: Dr. Michelle L. Kelley
The purpose of this study was to examine the role of children and mental illness in
women's compliance in a treatment program for substance abuse. Information was
retrieved from medical records of female clients (N= 221) who took part in a
community-based day treatment program for substance abuse in a large city in
southeastern Virginia during a 32-month period. It was anticipated that, as compared to
women who resided with minor children, women who did not reside with minor children
would have greater treatment success defined as: 1) more days in the treatment program;
2) higher percentage of negative toxicology screens during the treatment program; and (3
greater likelihood of treatment compliance. It was also anticipated that, as compared to
women who had mental illness, women with no mental illness would have also have
greater treatment success as defined above. It was further hypothesized that women with
both of these protective factors (e.g., no dependent children and no mental illness) would
have greater treatment success than woman with either or none of these protective
factors. Results demonstrated that neither dependent children nor mental illness, alone or
in combination had a significant impact on the number of days women stayed in
treatment or the percentage of negative toxicology screens; however, women with mental
illness tended to have more days in treatment. Furthermore, women with mental illness
were significantly more likely to be classified by the program staff as treatment
compliant than women without mental illness.
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treatment, whose wisdom and hard work helped better the lives of women and children
affected by substance abuse and dependence.
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1
INTRODUCTION
Substance abuse is a significant problem in the United States, with potentially
devastating effects, not only for the abusers, but also for their families. A recent survey
conducted by the Substance Abuse and Mental Health Services Administration
(SAMHSA, 2007) estimated 22.6 million persons met criteria for substance abuse or
dependence in the past year (9.2 percent of the population aged 12 or older). Of these,
3.2 million (14%) met criteria for abuse of or dependence on alcohol and illicit drugs, 3.8
million (17%) met criteria for abuse of or dependence on illicit drugs but not alcohol, and
15.6 million met criteria for abuse of or dependence on alcohol but not illicit drugs
(69%).
Although the criteria for substance abuse and substance dependence differ, both
cause problems in the user's life that may lead them to seek treatment and are referred to
collectively as "Substance Use Disorder" in the Diagnostic and Statistical Manual, 4th
Edition, of the American Psychiatric Association (DSM-IV). Substances whose use may
lead to life problems include nicotine, alcohol, illegal drugs (e.g., marijuana, cocaine,
heroin), and prescription drugs (e.g., oxycontin, vicodin, methadone, valium). While
both alcohol and nicotine are considered drugs due to their effects on the user,
researchers usually refer to "drugs" as those substances that are illegal or require a
physician's prescription. For the purpose of this study, "substance use and abuse" refers
to both alcohol and drugs, unless otherwise specified. In addition, the term "substance
abuse" is used liberally to include both substance abuse and substance dependence.
Several studies have shown that women have different patterns of substance use
and abuse compared to men (e.g., Greenfield, Manwani, & Nargiso, 2003). Although
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some studies have indicated that women have unique substance abuse treatment needs
compared to men (e.g., Jarvis, 1992; Vogeltanz & Wilsnack, 1997), because considerably
more research has focused on men, less is known about factors affecting women's
recovery. Only in relatively recent years, has there been a concerted effort to evaluate
women with substance use disorders; consequently, most treatment modalities are still
based on the earlier research that focused solely on men (e.g., Greenfield et al., 2007).
Although many differences may affect treatment outcome, two important characteristics
that may differentiate men and women's recovery from substance abuse are psychiatric
comorbidity and the parenting role. The purpose of this study was to examine
relationships between these factors on women's recovery from substance abuse.
Rates of Substance Use among Males and Females
Adolescents. Although drug and alcohol abuse are often conceptualized as
problems of men (Valliant, 1995), the rates of substance abuse for men and women are
increasingly similar. For instance, Greenfield et al. (2003) reported significant gender
differences in the prevalence of substance use disorders in the United States, but noted a
trend among boys and girls aged 12 to 17 years toward comparable rates of use and
initiation for alcohol, cocaine, heroin, and tobacco. In addition, although the rate of
substance abuse or dependence for females (6.3%) was approximately half as high as the
rate for males (12.3%), the SAMHSA (2007) survey found that among youths aged 12 to
17 the rate of substance abuse or dependence for females (8.1%) was similar to the rate
for males (8.0%). Similarly, Johnston et al. (2007) examined trends in alcohol use among
female and male adolescents over time (1975-2006) and found a slight decrease in rates
of use by males and a slight increase in rates of use by females.
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Several factors may have contributed to the closing of the gender gap in
adolescent substance abuse. These include stress, mood and anxiety disorders, and
specific changes in alcohol use. For instance, female adolescents are more likely than
males to use drinking to relieve stress (Simonov, Schoen & Klein, 2000). Related to this,
mood and anxiety disorders are more common among female adolescents than male
adolescents (Kuehner, 2003), which may lead to attempts at self-medication though illicit
drugs and alcohol.
The fact that adolescent females engage in drug use at rates that are similar to
adolescent males may indicate a future trend of increasingly similar rates of substance
abuse among men and women. If this trend continues, over time there may be a
narrowing of the male-to-female prevalence ratios of substance abuse in adults. The
increase in substance use and addiction among adolescent girls indicates a need for
further exploration both of the causes and treatment of substance abuse for females.
Adults. Although substance abuse and dependence appears to be a greater problem
for males than females, several studies have indicated significant gender differences in
the type of substances used and in the progression of abuse. When examining the use of
opiates, stimulants and alcohol, surveys have shown that women account for 35 to 60%
of the drug abusers or drug addicts in the U.S. (Kreek, 2000). Kandel (2000) reported
rates are higher for adult males than females for alcohol and marijuana dependence, but
essentially the same for cocaine dependence. Furthermore, recent studies have shown
that females are more likely to use crack-cocaine than males (Lejeuz, Bornovalova,
Reynolds, Daughters, & Curtin, 2007; Mangrum, Spence, & Steinley-Bumgarner, 2006).
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Blume and Zilberman (2004) attribute the increase in alcohol and drug use among
women to the increase of women in professions formerly dominated by men, the younger
age of onset for female substance abusers, and the finding that women have a higher risk
for developing dependence related to early use of substances. This possibility is
particularly disturbing because women have a heightened vulnerability to medical,
physical, mental, and social consequences of substance use. Women also carry additional
unique risks during pregnancy because of the potential effects of alcohol and drugs on
their unborn children. In addition, they have certain gender-specific cancer risks. Given
this and the declining age of initiation of substance use in women, prevention and
treatment efforts especially geared toward women (e.g., education of all medical and
paramedical staff, screening in primary care clinics, detection of drug use early in
pregnancy or before conception, brief interventions and treatment programs that integrate
women's needs) are exceedingly important to stop and ultimately reverse this trend.
Gender Differences Related to Alcohol Use and Abuse
Several psychosocial and demographic variables associated with problem
drinking in women appear to be distinct from the correlates of men's alcohol problems.
Drunkenness in men has typically been accepted by society and even encouraged at
times, whereas drunkenness in women has never been accepted. Consequently, there is
greater stigma associated with women's drinking. When women drink to excess it has
typically been considered unfeminine and has been associated with promiscuity and
immorality (Cohen, 2000). When female and male alcoholics are compared, women
report more positive family history of alcohol misuse, a later onset of drinking and
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related problems, more marital disruption, and more psychiatric comorbidity (Gomberg,
1999).
Although men drink more heavily than women, this difference may in part be due
to men's greater tolerance for alcohol due to their increased body mass. For instance,
binge drinking is typically defined as five consecutive drinks for men and four
consecutive drinks for women. Physiological differences between the sexes, including
hormonal, metabolic, endocrinological, and neuropsychological processes influence how
alcohol is processed and are at least partly responsible for the more rapid progression of
alcohol dependency and related disease processes (Brady & Randall, 1999; Greenfield &
O'Leary, 2002; Lieber, 2003; Tavares, Zilberman, Hodgins, & el-Guebaly, 2005).
Gender Differences in Reasons for Entering Substance Abuse Treatment
Reasons for entering substance abuse treatment differ for men versus women.
Mangrum et al. (2006) examined gender differences at pretreatment on the Addiction
Severity Index composite score. The Addiction Severity Index assesses lifetime and
recent (past 30 days) severity of problems in seven areas of functioning: alcohol, drug,
employment, family-social, legal, medical, and psychiatric. Results indicated that women
reported a greater number of problem days related to medical, employment, family,
social, and psychological problems, whereas men reported more problem days related to
drug or alcohol use. Similarly, in a study of clients in inpatient treatment for substance
abuse, DiNitto, Webb, and Rubin (2002) found that women reported greater concern
related to family problems and indicated a greater need for family counseling than did
men. Women also reported having closer relationships to and spending more time with
their children and family than did men.
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Gender Differences in Treatment for Substance Abuse and Dependence
Historically, addiction has been considered a disease of men, and differences
between male and female substance abusers were not appreciated by researchers or by
clinicians. Although the number of female clients in alcohol treatment programs
increased from 22% in 1982 to 28% in 1990, women were still substantially
underrepresented in many treatment programs (Vogeltanz & Wilsnack, 1997). Prior to
the mid-1990's little research had been conducted on women and their problems
associated with substance abuse (U.S. Department of Health and Human Services, 1994).
More specifically, in a review of English journal articles cited in the Medline and
Psychlnfo databases from 1975 to 2005, Greenfield et al. (2007) identified 280 articles on
treatment outcomes in women with substance use disorders. Ninety percent of those
articles were published since 1990 and over 40% of those had been published since 2000.
As such, drug and alcohol treatment programs were initially designed by and for
men with women admitted as an afterthought. Little attention was given to the specific
needs of female patients (Mondanaro, 1989). But, in fact, men and women not only
differ in the type of substances used and the progressions of substance abuse and
dependence, their treatment needs are also different.
A meta-analysis of gender differences in treatment outcome studies conducted by
Jarvis (1992) found that men had better results from inpatient programs that included
milieu therapy, psychotherapy and Alcoholics Anonymous with or without drug therapy;
conversely, most of the programs that reported better results for women used behavioral
therapies. Jarvis argued that treatment programs that take into consideration the different
needs of women are likely to experience greater success than those with a "one size fits
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all" approach. Childcare, assessment and treatment of mood and anxiety disorders, skills
training for increasing social, parental, and relationship functioning are important issues
for women, as well as assistance with practical issues such as employment, housing, and
health care (Vogeltanz & Wilsnack, 1997). According to Vogeltanz and Wilsnack, about
53% of public and private alcohol and drug abuse treatment facilities offered some type
of women's services; however, only 6% of the total treatment programs were for women
only, an increase from 3% in 1982. In a review of the Alcohol and Drug Services Study
(ADSS) conducted by the U.S. Department of Health and Human Services, Brady and
Ashley (2005) found that women-only treatment availability ranged from about 2 percent
of outpatient nonmethadone facilities to 21 percent of nonhospital residential facilities
According to Kaufman (1994), many of the issues of female substance abusers are
significantly different from those of male substance abusers. Although the number of
female clients in alcohol treatment programs increased from 22% in 1982 to 28% in
1990, women were still substantially underrepresented in many treatment programs
(Vogeltanz & Wilsnack, 1997). The need for gender-specific treatment has been
supported by several studies that have identified differences in interaction styles and the
traditional societal dominance of men as factors that might have a negative impact on
women in mixed-gender treatment programs (e.g., Hodgins, el-Guebaly, & Addington,
1997; LaFave & Echols, 1999; Nelson-Zlupko, Kaufman, & Dore, 1995; Schliebner,
1994; Welle, Falkin & Jainchill, 1998). Whereas traditional treatment programs use a
confrontational style, better suited to men (Kauffman, Dore, & Nelson-Zlupko, 1995),
women may benefit from a less structured and rigid style of treatment (Hodgins et al.,
1997). According to aNIDA funded study conducted by Christine E. Grella of the

8

University of California at Los Angeles (UCLA), women in women-only treatment
programs were more than twice as likely to complete treatment compared to women in
mixed gender programs (NIDA Notes, March, 2000). Based on this analysis of 4,117
women participating in publicly funded substance abuse treatment programs in Los
Angeles from 1987 to 1994, Grella concluded that women have different treatment needs
than men and are more likely to be successful in gender-tailored treatment.
Women also have different risk factors, natural history, presenting problems,
motivations for treatment, and reasons for relapse compared to men (Davis, 1994;
Hodgins et al., 1997; Hughes et al., 1995; Pelissier, Camp, Gaes, Saylor, & Rhodes,
2003; Saunders, Baily, Phillips, & Allsop, 1993; NIDA Notes, September, 2000).
Women often turn to drinking due to a specific life situation and most often follow a
pattern of drinking alone. Furthermore, they may prove more harmful in their drinking to
themselves and others, and may show poorer results in treatment than men (Corrigan,
1980). Because heavy drinking is less acceptable for women than for men, alcoholabusing women may perceive more stigma and shame than alcoholic men (Corrigan,
1980).
Typical problems presented by women entering treatment include few vocational
skills, few social supports, low self-esteem, negative images of other addicted women,
ambivalence about associating with non substance users, complex domestic
entanglements, commitment and loyalty to a man, pessimism about the possibility of
positive change, mistrust of the treatment setting, and multiple other problems in living
(Wildwind & Samson, 1981). Women entering treatment are also more likely than men
to have the major caretaking and financial responsibility for their children; however, they
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are also more likely to have fewer financial resources (Mondanaro, 1989). Furthermore,
women often have a substance-abusing partner and get less support for treatment from
their family members and partners than do men (Blum, Nielsen, & Riggs, 1998).
A more recent study by Hser, Evans and Huang (2005) confirmed the gender
differences from previous findings. They found that women began treatment with more
severe psychosocial problems, including depression, than their male counterparts,
whereas men reported more crime and involvement with the criminal justice system. In
addition, the National Institute on Drug Abuse (May, 2002) concluded that, based on a
review of NIDA research, the effectiveness of treatment may be enhanced by tailoring
services to the gender of the recipient. This conclusion was based on the findings that
success in treatment is directly related to the length of time in treatment, and women tend
to leave treatment earlier than men. Furthermore, men tend to relapse due to anxiety and
positive feelings, while women tend to relapse due to depression and negative feelings.
Role of Parenting and Psychiatric Comorbidity in Women's Recovery Attempts
Although the needs of women entering treatment for substance abuse are different
than their male counterparts, two of the most distinguishing characteristics that
differentiate men from women with substance use disorders are the role of children in
their lives and psychiatric comorbidity. As such, the following sections focus on these
critical issues in women's recovery from substance abuse.
Role of Parenting in Women's Recovery Attempts. Nearly 5 million substanceabusing adults are believed to be living with at least one minor child (SAMHSA, 2004a).
Another SAMHSA report (2004b) found that for women living with children, 5.5% were
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substance abusers, whereas for women not living with children, 13% were substance
abusers.
It has been argued that having dependent children is a women's issue that must be
addressed in treatment (Jansson et al., 1996; Knight, Hood, Logan & Chatham, 1999;
Nelson-Zlupko et al., 1995; SAMSHA, 1993; Volpicelli, Markman, Monterosso, Filing,
& O'Brien, 2000). Compared to their male counterparts, women who abuse substances
are more likely to have children (Mangrum et al., 2006), are more likely to be living with
their minor children (Pilowsky et al., 2001), and are more likely to be the primary
caregiver for their children (Stewart, Gossop, & Trakada, 2007). Moreover, Kearney,
Murphy, and Rosenbaum (1994) found that even when substance-abusing mothers
resided with other adults, they were still likely to be their children's primary caregiver.
It is not clear what role dependent children may play in women's recovery.
Children may serve as either a barrier to or a motivation for treatment. For women with
substance abuse problems, children are frequently considered invisible members of their
social networks (Kroll, 2004) and may serve as a source of support and encouragement.
On the other hand, parenting may be a competing demand that may be associated with
women's decision to drop out treatment (Daley et al, 2000). Women might also drop out
of treatment due to feeling overwhelmed by guilt and shame due to the impact their
substance use has had on their children (Cox, 2000). In addition, fear of involvement
with the child welfare system may prevent many women from seeking help for their
substance abuse problems (Kissman & Torres, 2004).
In a study of female crack or cocaine users, Kearney et al., (1994) found that
women who lived with their minor children and had parenting responsibilities reported
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less drug use. For some of these women, losing custody of their children was associated
with increased drug use. For women who had lost custody of their children, increased
drug use was hypothesized as an attempt to cope with the pain of the loss of their
children. For other women, the loss of custody of their children motivated them to
decrease their drug use in order to regain custody of their children.
Some studies of drug-using women with dependent children have found that
children may influence their decision to reduce substance use. Woodhouse (1992) found
that parenting was a theme that surfaced for many of the women in a qualitative study of
26 mothers in inpatient treatment for substance abuse. Women reported concern about
the effect their substance abuse was having on their children and worried about their
children modeling their substance abuse behavior. The mothers also reported a sense of
responsibility for taking care of their children; however, many women did not know how
to create a better home environment for their children and therefore managed to continue
drug use and maintain responsibility for their children by leaving their children in the
care of friends or family members when they used drugs.
Kearney et al. (1994) revealed similar findings in a study of cocaine-using
mothers. Although many of these women had unplanned pregnancies, they reported a
sense of responsibility for and pride in their children when they were born. Many mothers
also reported they spent the majority of their time with their children and would only do
drugs when the children were not present. Some mothers also reported a willingness to
admit their drug habits to authorities for the well being of their children. In addition,
some mothers reported they would give up custody of their children, even though it
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would cause them great pain to do so, if their drug use interfered with their ability to
provide proper childcare.
Some substance-abusing women have reported having greater control over their
drug use when they were caring for their children compared to when they did not have
child care responsibility (Roberts, 1999). In Robert's study of inner city African
American women, the mothers described their children as being very important in their
lives. Furthermore, women who had experienced failed relationships and who did not
have children living with them reported greater substance use problems than women who
had similar relationship problems but did have children living with them. In addition,
losing custody of children resulted in women increasing their drug use. Most of these
women reported their primary motivation for entering treatment was an attempt to get
their children back.
Feeling inadequate, as a mother, has been associated with increased drug use. In
studies conducted by Hardesty and Black (1999) and Woodhouse (1992) motherhood was
an important part of the lives of women addicted to drugs. Many women reported that
repairing their relationship with their children was a motivation for their recovery from
drug addiction. However, for many women, their drug use made it difficult to repair
relationships with children, which led them to feel guilty.
Collectively, these qualitative studies demonstrate the importance of children in
the lives of substance-abusing mothers and suggest that many women who misuse
substances are concerned about the effects of their drug use on their children. In addition,
many women reported concerns about how their drug use was associated with their
ability to effectively parent their children. Furthermore, for many women, their children
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served as a motivation to enter treatment. For some women, the loss of custody was
associated with increased reports of drug use; however, the loss of custody of children
served to motivate some women to discontinue drug use and increase parenting skills in
an attempt to regain custody of their children.
Substance Abuse Treatment for Women with Children. Considerable research has
been conducted on mothers in residential treatment settings for substance abuse. Conners,
Grant, Crone, and Whiteside-Mansell (2006) found that length of stay in residential
treatment was positively associated with positive treatment outcomes, including
abstinence from alcohol and other drug use, decreased cigarette use, decreased
depression, and more positive parenting attitudes. In a study that examined various forms
of treatment for substance abuse, including residential treatment, Stewart et al. (2007)
found that women with children had unique difficulties that may prevent them from
seeking and benefiting from treatment. Specifically, Stewart and colleagues examined
drug dependent parents' involvement in treatment services, their childcare arrangements
before and during treatment, and their treatment outcomes one year later. As compared
to women who did not have childcare responsibilities, women who had childcare
responsibilities reported little improvement in psychiatric symptoms. Also, mothers who
took care of their children were less likely to enter residential treatment than women who
were not caring for their children.
Although a substantial body of literature has examined women's recovery
attempts, much less research has examined how minor children in the home may serve as
a barrier or benefit to women's outpatient treatment for substance abuse. Studies that
have examined women who enter non-residential community-based treatment, suggest
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that having children may be a barrier to receiving treatment services. For instance,
McMahon, Winkel, Suchman, and Luthar (2002) examined the number of children
women had and treatment history for methadone maintenance treatment. They found a
significant negative correlation between number of children and number of previous
treatments. That is, the more children opioid-addicted women had, the less likely they
were to attempt drug abuse treatment. In a community-based substance abuse treatment
program study, Wilke, Kamata, and Cash (2005) found a negative relationship between
having children and treatment motivation, suggesting that having children may be an
obstacle to entering treatment. It is possible that these women were afraid to enter
substance abuse treatment for fear of losing their children to Child Protective Services
and/or concern that they would be unable to care for children while in treatment.
Psychiatric Comorbidity among Female Substance Users. The occurrence of
depression and anxiety among female alcohol and drug users is well established. Women
with substance use disorders present higher rates of psychiatric comorbidity, particularly
mood and anxiety disorders, than do men. Moreover, the comorbid diagnosis, particularly
of depression, is more often primary in women. In contrast, for men comorbidity is more
often secondary to the substance abuse diagnosis. In addition, there is evidence that
psychiatric comorbidity is associated with distinct, sex-specific outcomes for substance
use treatment (Zilberman, Tavares, Blume, el-Guebaly, 2003). The most common
comorbid disorders in women with alcohol use disorders are depression and anxiety
disorders, whereas the most common comorbid disorders in alcoholic men are antisocial
personality disorder and other substance use disorders (Helzer & Pryzbeck, 1988). Men
are more likely to identify alcohol as the cause of their problems in daily living, whereas
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women are more likely to identify anxiety, depression, and difficulties in daily living as
the problems that cause their alcohol use. Affective disorders appear equally prevalent in
men and women (Kreek, 2000). Women who seek treatment for substance abuse are at
greater risk than men of suffering from non-bipolar mood disorders and are more likely to
seek treatment for their disorder. Major depression is often complicated by the cooccurrence of alcohol and drug abuse or dependence. Nearly one-third of patients with
major depressive disorder also have substance use disorders, with a higher risk of suicide
and greater social and personal impairment in addition to other psychiatric problems.
In a review of the literature, Chander and McCaul, (2003) found a clinically
important comorbidity between psychiatric and substance use disorders, particularly in
women. Women with affective and anxiety disorders were more likely to present with
alcohol or drug abuse/dependence and, in turn, substance-abusing women were more
likely to experience clinically significant depression and anxiety. Emerging evidence
points to an etiological role for anxiety disorders in the development of substance
abuse/dependence; however, etiologic evidence is not as clear-cut for major depressive
disorder. In addition, Post-Traumatic Stress Disorder (PTSD) appears to be a particularly
important factor for alcohol and drug dependence in women who have experienced
childhood or adult sexual and or physical abuse (Chander & McCaul, 2003).
Psychiatric Comorbidity and Substance Abuse Treatment. One of the most
significant predictive factors of treatment outcome, psychiatric comorbidity, is found
more frequently in women than men with substance abuse (Alonso et al., 2004; Castel,
Rush, Urbanolki & Toneatto, 2006; Chander & McCaul, 2003; Lewis & Petry, 2005;
Peles, Schreiber, Naumovsky, & Adelson, 2007). Studies have shown that at the time of
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entry into methadone maintenance treatment for heroin addiction, women have a different
profile of psychiatric comorbidity. Specifically, anxiety disorders are more prevalent in
women than men, and antisocial personality disorders are more prevalent in men than
women.
The Chander and McCaul (2003) review found limited evidence that womenspecific services can improve treatment retention, substance use outcomes, and possibly
psychosocial functioning compared with traditional mixed-gender programs. However, it
was clear women with co-occurring psychiatric and substance use problems are
challenging to engage and retain in care. Particular attention should be focused on
screening and assessment of alcohol and drug use and problem severity among women
who have identified psychiatric disorders or who are receiving antidepressant or
anxiolytic medications. Recognition and referral for both psychiatric and substance use
disorders are critical for long-term health and psychosocial improvement. Although the
treatment of comorbid major depressive disorder and substance use disorders with
medication is likely effective, the differential treatment effects based on substance use
disorder comorbidity have been understudied.
Conner, Pinquart, and Duberstein (2008) conducted a meta-analysis of reports on
intravenous drug users published in English in peer-reviewed journals since 1986 that
contained data on depression and substance use outcome. They examined the association
of depression with substance-related behaviors including concurrent drug use and
impairment, future drug use and impairment, alcohol use and impairment, needle sharing
and substance use treatment participation, and identified moderators of these associations.
Positive associations between depression and the substance-related variables were
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reported, with the exception of the predicted association of depression and future drug
use and impairment. Moderating effects of gender were identified, including greater
associations of depression with substance use treatment participation and needle sharing
among women, and a greater association of depression with future drug use and
impairment among men.
Role of Dependent Children and Mental Illness in Outpatient Substance Abuse Treatment
Motherhood appears to be an important factor in women's substance abuse
recovery attempts. Unfortunately, few studies have examined whether having minor
children may be related to women's attendance in a community-based outpatient
treatment program and whether having young children may be associated with successful
treatment compliance. Although the majority of previous research reviewed has
examined whether children may be related to women's treatment compliance, length of
time in treatment has also been related to treatment success. For example, Conners et al.
(2006) found that a longer stay in residential treatment was associated with greater
abstinence from alcohol and other substances.
Data from the 2002 and 2003 National Survey on Drug Use and Health were
evaluated by Simmons and colleagues (2009) who found that of the 19,300 women
surveyed who reported having children younger than 18 years in the home, 1.9% reported
past year abuse or dependence on cocaine, heroin, marijuana, stimulants, hallucinogens
or nonmedical use of prescription medication. These mothers were more likely to be
unmarried, report stress, have poorer health status, and meet the criteria for serious
mental illness (SMI). In addition, Graff et al. (2009) examined retention and engagement
for 102 women in gender-specific treatment. They found that women were more engaged
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in treatment (i.e., completed more assigned homework) if they had fewer children at
home.
Summary
Two important variables related to successful substance abuse treatment for
women are psychiatric comorbidity and having minor children; however, few studies
have addressed both of these major issues and how both may be related to treatment
compliance. Although it is known that mental illness is a risk factor for successful
substance abuse treatment, it is less clear what role children play. Some research
suggests that the presence of children in the home may be a protective factor for women
seeking treatment, serving as a motivation for seeking recovery and staying sober. Other
research suggests that the presence of children in the home may keep women from
seeking the treatment they need, especially inpatient treatment. It is not known what role
dependent children play in the lives of women with serious mental illness who seek
treatment for substance abuse. However, based on this review of the limited research
conducted in this area, the studies that support the hypothesis that children can be a
protective factor in women's recovery are largely qualitative and based on small sample
sizes, while the studies that support the hypothesis that children may be a risk factor in
women's recovery are largely quantitative and have much larger sample sizes. Therefore,
for the purpose of this study it was decided to treat the presence of dependent children as
a risk factor for women who are seeking treatment for substance abuse.
Study Hypotheses
The purpose of the present investigation was to examine the role of children and
mental illness in women's compliance in a community-based day treatment program for

substance abuse. Although there is no consensus in the research literature on whether
children are a protective or risk factor for women's substance abuse treatment, it was
hypothesized that, as compared to women who have minor children, women who do not
have minor children would have greater treatment success as defined by: (1) more days in
the treatment program; (2) greater likelihood of treatment compliance (i.e., successful
compliance in the program); and (3) a higher percentage of negative toxicology screens
during the treatment program. Additionally, it was hypothesized that, as compared to
women with mental illness, women not classified with mental illness would also have
greater treatment success, as defined by: (1) more days in the treatment program; (2)
greater likelihood of treatment compliance (i.e., successful compliance in the program);
and, (3) a higher percentage of negative toxicology screens during the treatment program.
It was further hypothesized that women with both of these protective factors (e.g., no
dependent children and no mental illness) would have greater treatment success than
woman with either or none of these protective factors.
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METHOD
Participants
Archival data were examined from women (N= 221) ranging in age from 19 to 59
years old (M= 36.40, SD = 8.85) who took part in a community-based day substance
abuse treatment program in a large city in southeastern Virginia between December 2003
and August 2006 (inclusive). Participants had been screened by program staff prior to
admission and found to meet current alcohol or drug abuse or dependence criteria
according to the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSMIV; American Psychiatric Association, 1994). Demographic information for the sample is
listed in Table 1. Prior to data collection IRB approval was obtained from the
participating university. The community services board (CSB) sponsoring the program
also approved the study.
Procedure
In an attempt to form an alliance with the local CSB, university researchers met
with CSB staff to discuss their mutual interest in outpatient substance abuse treatment
programs for women. Both the researchers and the CSB were interested in treatment
retention and improving services for clients who sought treatment for their addiction to
drugs or alcohol. Although the CSB had been collecting extensive data on their clients,
they had no frame of reference or resources for analyzing their data. A thorough review
of the client variables that had been entered in their medical records, revealed a wealth of
information that might provide insight into protective and risk factors for treatment
retention, completion, and success. The data for this study is a subset of that larger data
collection.
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Table 1
Sociodemographic Characteristics of Clients (N = 221)
Characteristic

M

SD

Annual income (in U.S. dollars)3

2,300

3,527

Age

36.40

8.85

N (%)

Education

Grades 1 to 11
High School Graduate/GED
1, 2, or 3 years of college
College Graduate/Graduate
Degree
Unknown

Racial/ethnic
Composition

Caucasian
African American
'Other'
Unknown

50 (22.6)
162 (73.3)
7(03.2)
2 (00.9)

Living
Arrangements

Alone
With relatives
With non-relatives
With relatives and non-relatives
Unknown

41 (18.6)
134(59.7)
39 (17.6)
4 (01.8)
5 (02.3)

Primary Drug

Alcohol
Crack/Cocaine
Heroin
Marij uana/Hashish
Methamphetamines
Other Opiates or Synthetics
Other Stimulants
Unknown

56 (25.3)
109(49.3)
8 (03.6)
30(13.6)
1 (00.5)
3 (01.4)
1 (00.5)
13 (05.9)

Legal Status

None/Voluntary Admission
Involuntary
Unknown
Note. Demographic variables reflect admission data.
a

94
85
20
7
15

(42.5)
(38.5)
(09.0)
(03.2)
(06.8)

138 (62.4)
72 (32.8)
11 (05.0)

Mode for income was zero. Ninety-seven percent of clients were below 2004 poverty

level of $9,310 established by the U.S. Department of Health and Human Services.
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The CSB provided a Day Treatment Program for women with substance abuse
and/or dependency. The structured program was designed to offer a minimum of 20
onsite treatment hours per week for a three-to-twelve month period with the actual length
of stay being determined by the severity of the client's problems. In order to be admitted
to the program, women had to meet the following criteria: 1) DSM-IV diagnosis of
substance (drugs or alcohol) abuse and/or dependence; 2) not be in need of inpatient
treatment; 3) not be likely to respond successfully to more traditional, less intensive
treatment; and/or 4) be at risk for serious biopsychosocial problems if drug/alcohol use
was continued. Exclusion criteria included: 1) oppositional characteristics that limited
openness to behavioral interventions; 2) unstable medical conditions; 3) history of violent
behavior that contraindicated participation in group activities; 4) active suicidal or
homicidal intent; and/or 5) any other acute problems that would prohibit benefit from
group interventions. Services were provided on an outpatient basis and included group
therapy, educational sessions (e.g., Self-Esteem, Barriers to Recovery, Chemical Aspects
of Addiction, Healthy Decision Making, Family Roles), presentations from community
partners (e.g., HIV/AIDS Prevention), employment preparation activities and random
weekly urine drug screening. Structured 12 week modules of treatment were scheduled
daily from 9:30 a.m. to 1:30 p.m. Monday through Friday.
Non-identifying participant information was collected from medical records. For
women who had more than one substance abuse treatment attempt during the study time
frame, the information collected from their medical records reflected their most recent
substance abuse treatment. All information was extracted from medical records by a
research assistant and verified by a second research assistant. Every attempt was made to
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verify that missing data were not simply misplaced or located elsewhere in the client's
medical chart.
Dependent Children. At intake, clients were interviewed by CSB staff regarding
their current living arrangements, number and ages of any children, and so forth.
Information was also extracted from medical records on the number of live births and
their children's ages. Of the 221 women who attended treatment, 105 (47.5%) women
resided with a minor child at the time of intake; 116 (52.5%) did not reside with a minor
child at the time of intake. If participants reported having one or more dependent
children at intake, they were coded as ' 1' (n = 105); if they did not report having minor
children (between the ages of 0 and 17) at intake, they were coded as '2' (n = 116).
Mental Illness. A clinical interview was conducted at intake by CSB staff to
determine whether or not clients had any comorbid psychiatric conditions. Intake staff
used the DSM-IV multiaxial assessment to evaluate participants on clinical disorders
(Axis I), personality disorders and mental retardation (Axis II), general medical
conditions (Axis III), psychosocial and environmental problems (Axis IV) and global
assessment of functioning (Axis V). All participants had at least one Axis I diagnosis of
a substance-related disorder. Thirty-five percent had a comorbid disorder on Axis I, 60%
had only a substance-related disorder, and data were missing for six percent. If
participants were diagnosed with any clinical disorders on Axis I other than substancerelated disorders, they were coded as ' 1' (n = 77); if they were not diagnosed with any
clinical disorders on Axis I other than substance-related disorders, they were coded as '2'
(n= 131). Mental illness data were missing for 13 clients. See Table 2 for a list of
diagnoses for those classified with mental illness. No participants were diagnosed with
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Table

1

Axis I (DSM-IV) Diagnoses of Clients Classified with Mental Illness (N-77)
Diagnosis

Number of Clients

Schizophrenia

4

Schizoaffective Disorder

9

Psychosis, NOS

3

Maj or Depressive Disorder

21

Dysthymic Disorder

2

Depressive Disorder, NOS

19

Mood Disorder, NOS

2

Bipolar Disorder

18

Panic Disorder

1

Posttraumatic Stress Disorder

5

Generalized Anxiety Disorder

2

Anxiety Disorder, NOS

4

Adjustment Disorder

2

Attention-Deficit Hyperactivity Disorder
2
Note. NOS=Not otherwise specified. Some clients had more than one diagnosis on Axis
1. No clients had Attention-Deficit Hyperactivity Disorder as a sole Axis I diagnosis.

mental retardation on Axis II and less than 10% were diagnosed with a personality
disorder on Axis II. See Table 3 for a list of Axis II diagnoses.
Treatment Outcome Based on Days in Treatment. Number of days in treatment
was extracted from the medical records by calculating number of days from program
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Table

1

Axis II (DSM-IV) Diagnoses of Clients at Program Intake (N=221)
Diagnosis

N (%)

Antisocial Personality Disorder

6 (2.7)

Borderline Personality Disorder

3 (1.4)

Dependent Personality Disorder

1 (0.5)

Personality Disorder, Not Otherwise Specified

8 (3.6)

None

123 (55.7)

Diagnosis Deferred3
Missing"

20 (9.0)
60(27.1)

Total
221 (100.0)
a
Axis II diagnosis could not be confirmed or ruled out at time of intake.
b

No information was recorded on Axis II.

admission to program discharge. Number of days in treatment ranged from 1 to 450 {M=
116.56 days, SD = 98.80).
Treatment Outcome Based on Percentage of Negative Toxicology Screens.
Participants were randomly administered toxicology screens during the course of
treatment. The number of toxicology screenings ranged from 0 to 46 (M= 6.31, SD =
7.69). The toxicology screens tested for the following substances: propoxyphene,
amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol,
methadone, and opiates. If a client tested positive for any of these substances, the screen
was considered positive. In order for a toxicology screen to be considered negative, the
client must have tested negative for all substances on the screen. The number of negative
toxicology screens was divided by the total number of toxicology screens to determine
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the percentage of negative toxicology screens. For purposes of data analysis, participants
with less than 80% negative toxicology screens were coded ' 1' («=108); participants with
80% or higher negative toxicology screens were coded '2' (n=l\).

Toxicology screen

data were missing for 42 participants (19%).
Treatment Outcome Based on Treatment Compliance. At discharge, each client's
treatment was classified as either compliant, partially compliant, or non-compliant based
on concurrence by at least two program staff, one of which was the client's primary
counselor. Although the following behavioral criteria were listed in the treatment
program manual, staff were encouraged to consider each individual client's abilities and
level of understanding when making a treatment compliance classification. Therefore, a
client need not have met every behavioral criteria listed in order to be considered
compliant. Treatment compliance was based on the following criteria: 1) achieved
majority of goals/objectives of their treatment plan; 2) abstained from alcohol and other
drugs while in the program; 3) maintained a good attendance record; 4) developed a
recovery program; and 5) achieved maximum treatment potential. A client could be
considered partially compliant if she had successfully completed part of her treatment
plan but had to terminate treatment early due to special circumstances such as moving out
of the geographical treatment catchment. Clients could be considered non-compliant if
they: 1) achieved few goals/objectives of their treatment plan; 2) abstained from alcohol
and other drugs only periodically; 3) had a poor attendance record; 4) were unwilling to
develop recovery tools; and/or 5) achieved minimum treatment potential. Clients could
also be considered non-compliant if they: 1) were unable to participate fully due to health
problems; 2) were asked to leave the program due to non-compliance; 3) jeopardized or
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disrupted the safety or treatment of others; 4) had repeated attendance problems (i.e., ten
unexcused absences in one month); 5) refused services; 6) were incarcerated; and/or 7)
dropped out of the program. Women who were treatment compliant and women who
were partially compliant were combined and coded as ' 1' (n = 50) for data analytic
purposes. Women who were not treatment compliant were coded as '2' (n = 136).
Treatment compliance data were missing for 35 clients.
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RESULTS
The data were screened for duplicate records, outliers, and missing information.
Scores were screened for outliers based on the recommendation from Tabachnick and
Fidell (2007), that is, scores with an absolute z value of 3.3 or higher were considered
outliers. In the sub-sample of women who did not have minor children, one outlier was
found for the variable, days in treatment (i.e., 510 days in treatment). As suggested by
Tabachnick and Fidell, this score was replaced with 450 days in treatment (1 day greater
than the next highest value for days in treatment, 449). No other outliers were identified.
Normality for days in treatment and the percentage of negative toxicology screens were
examined with histograms and skewness and kurtosis statistics. Days in treatment was
positively skewed; percentage of toxicology screens had a bimodal distribution.
Consequently, a log transformation was performed on the variable days in treatment prior
to statistical evaluation; percentage of negative toxicology screens was recoded into a
binomial variable with a cutoff of 80%. Post-hoc analyses indicated that more days in
treatment was significantly positively correlated with negative toxicology screens, r (175)
= .31, p < 01. Because it cannot be assumed that missing data reflect true randomness,
missing data were not replaced. Rather, cases were deleted only for the analysis in which
data were missing.
Prior to hypothesis testing, the data also were examined for possible group
differences in sociodemographics. Specifically, women with and without dependent
children, and women with mental illness and without mental illness, were compared on
age, race/ethnicity, education, and primary drug of abuse using t tests and chi-square
analyses as appropriate. With the exception of age, there were no significant
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sociodemographic differences found between women with and without dependent
children. Women with dependent children were significantly younger (M=34.08 years,
SD=1.80) than women without dependent children (M=38.50 years, SD=9.25).
Specifically, women with dependent children were approximately four years younger
than women without dependent children. To control for this difference, age was included
as a covariate in the analyses that compared women with children to women without
children.
Comparisons between Dependent Children and Mental Illness on Days in Program
A two-way factorial ANOVA was performed to examine for main effects and
interaction effects of children and mental illness on days in treatment program.
Participant age was entered as a covariate. Assumptions of ANOVA were met including
normality of distribution and homogeneity of variance. No significant differences were
found between women with dependent children and women without dependent children
on days in treatment. In addition, no significant differences were found between women
with mental illness and women without mental illness on days in treatment. Furthermore,
the interaction effect between dependent children and mental illness was not significant.
However, one analysis approached significance F(l,198)=3.31,/?=.07, in that women
with mental illness had more days in treatment (M=126.87) than women without mental
illness (M= 106.18). See Table 4.
Comparisons between Dependent Children and Mental Illness on Toxicology Screens
A binary standard logistic regression was performed to test the prediction that
women without dependent children would have a significantly greater percentage of
negative toxicology screens than women with dependent children and that women
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Table

1

Summary of Two-Way Analysis of Variance for Dependent Children and Mental Illness
on Days in Treatment (N=203)

Source

SS

df

MS

F

Partial
Tl2

Observed
Power

Age

1

2.13

2.13

2.56

.013

.357

Dependent Children

1

1.43

1.43

1.72

.009

.257

Mental Illness

1

2.76

2.76

3.31

.016

.441

Dependent Children x Mental
Illness

1

1.48

1.48

1.78

.009

.264

198

164.78

0.83

Within cells

Total
3997.54
203
Note. Due to significant differences within the IV Dependent Children, age was entered
as a covariate. SS and MS were the same for all variables. No results were significant at
p<. 05.

without mental illness would have a significantly greater percentage of negative
toxicology screens than women with mental illness. For the purpose of data analysis the
following variables were recoded: percentage negative toxicology screens ('0'= <80;
T=>_80); dependent children ('O'=none; 'l'=one or more); mental illness ('0'=no;
' 1 ,= yes). The variables dependent children and mental illness were entered
simultaneously into the model, as was their interaction. Because women with dependent
children were significantly younger than women without dependent children, age was
entered as a covariate. Results of the logistic regression were not significant, that is, the
model did not predict odds of a percentage of negative toxicology screens. See Table 5.
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Table 1
Binary Standard Logistic Regression Predicting Percentage of Negative Toxicology
Screens - First Model (N=168)
Variable

B

SE

Wald
statistic

Odds ratio
(95%CI)

Dependent Children

-0.56

0.43

1.71

0.57(0.25-1.32)

Mental Illness

0.63

0.43

0.02

1.06 (0.46-2.48)

Dependent Children x Mental Illness

0.62

0.66

0.89

1.86 (0.51-6.73)

Age
0.01
0.02 0.08
1.01 (0.97-1.04)
2
''
Note. R = .02 for first regression model. CI=Confidence Interval. No significant
predictors at p<.05.

As suggested by Tabachnick and Fidell (2001), because age was not a significant
predictor in the first model, the model was again run without this covariate. This
modified model was also not significant. See Table 6. The model was modified once
again by removing the interaction between the predictor variables and again, the model
was not significant. See Table 7.
Comparisons between Dependent Children and Mental Illness on Treatment Compliance
A binary standard logistic regression was performed to test the prediction that
women without dependent children would be more treatment compliant than women with
dependent children and that women without mental illness would be more treatment
compliant than women with mental illness. For the purpose of data analysis the
following variables were recoded: treatment compliance ('O'=noncompliance;
'Incompliance); dependent children ('O'=none; T = o n e or more); mental illness
('0'=no; ' 1 '=yes). The variables dependent children and mental illness were entered
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Table

1

Binary Standard Logistic Regression Predicting Percentage of Negative Toxicology
Screens - Second Model (N=168)
Variable

B

SE

Wald
statistic

Odds ratio
(95%CI)

Dependent Children

-0.58

0.42

1.91

0.56(0.25-1.27)

0.65

0.43

0.02

1.07(0.46-2.49)

Mental Illness

Dependent Children x Mental Illness
0.62
0.66 0.88
1.85 (0.51-6.69)
2
—
Note. R = .02 for second regression model with covariate age removed.
CI=Confidence Interval. No significant predictors atp<.05. .

Table 7
Binary Standard Logistic Regression Predicting Percentage of Negative Toxicology
Screens - Third Model (N=168)
Variable

B

SE

Wald
statistic

Odds ratio
(95%CI)

Dependent Children

-0.33

0.32

1.06

0.72(0.38-1.35)

0.32

1.04

1.39(0.74-2.64)

Mental Illness

MINIMUM

0.33

LIMN.
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Note. R = .01 for third regression model with covariates age and interaction removed.
SE the same for both independent variables. CI=Confidence Interval. No significant
predictors at p<. 05.
simultaneously into the model, as was their interaction. Because women with dependent
children were significantly younger than women without dependent children, age was
entered as a covariate. The model did not predict treatment compliance. See Table 8.
Because age was not a significant predictor, the model was again run without this
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Table 1
Binary Standard Logistic Regression Predicting Treatment Compliance - First Model
(N=183)
Variable

B

SE

Wald
statistic

Odds ratio
(95%CI)

Dependent Children

0.79

0.46

0.03

1.08 (0.44-2.67)

Mental Illness

0.55

0.83

1.35

1.73 (0.68-4.45)

Dependent Children x Mental Illness

0.37

0.69

0.28

1.44 (0.37-5.60)

Age
-0.02
0.02
0.69
0.98 (0.95-1.02)
2
Note. R = .03 for first regression model. CI=Confidence Interval. No significant
predictors at p<.§5.

covariate. The modified model was not significant. See Table 9. The model was
modified again by removing the interaction between the predictor variables. Although
this model did not meet traditional levels of statistical significance, X (2) = 5.00,/?= 08,
R -.03,
it did approach significance. More specifically, while dependent children was
not a significant predictor of treatment compliance in the final model, women with
serious mental illness were significantly more likely to be rated as treatment compliant
X\\)

= 4.69,p< .05, odds ratio=1.37. See Table 10.
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Table 1
Binary Standard Logistic Regression Predicting Treatment Compliance - Second Model
(N=183)
Variable

B

SE

Dependent Children

0.15

Mental Illness
Dependent Children x Mental Illness
......... 1.H1I1.IU

I I II

MNIWWMIIITIWFMIIM

.......I.I

1.1......1............

0.45

Wald
statistic
0.12

Odds ratio
(95%CI)
1.17(0.49-2.82)

0.57

0.48

1.44

1.77 (0.70-4.51)

0.37

0.69

0.29

1.45 (0.37-5.60)

111111

11.

•JMIJIIIIIIIIIIIIIIIIIIJIINIINIIMMJ

1 ,,11 1111 1 111

IHHIMIIIIIIIIIIHHNIIIIIIIUUJJJIIIIIII.

I

Note. R = .03 for second regression model with covariate age removed. CI=Confidence
Interval. No significant predictors atp<.05.

Table 10
Binary Standard Logistic Regression Predicting Treatment Compliance - Third Model
(N=183)
Variable

B

SE

Dependent Children

0.31

Mental Illness

0.75

0.34

Wald
statistic
0.84

Odds ratio
(95%CI)
1.37(0.70-2.68)

0.35

4.69*

2.12(1.07-4.17)

Note. R1 = .03 for third regression model with covariates age and interaction removed.
CI = Confidence Interval
*/K.05
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DISCUSSION
The purpose of this study was to examine the influence of having dependent
children and/or mental illness on women's outpatient substance abuse treatment. It was
hypothesized that both having dependent children in the home and mental illness would
negatively impact treatment outcome, resulting in significantly fewer days in treatment,
significantly lower percentage of negative toxicology screens, and significantly less
likelihood of treatment compliance. However, results demonstrated that neither of these
factors, either alone or in combination had a significant impact on the number of days
that women stayed in treatment. This is in contrast to the review by Chander and McCaul
(2003) who found that women with substance abuse and psychiatric comorbidity were
more difficult to retain in treatment and the research by Graff et al. (2009) that found
women were more engaged in treatment if they had fewer children at home.
In contrast to the hypothesis that women with mental illness would spend
significantly fewer days in treatment, it was noted that women with mental illness tended
to have more days in treatment than women without mental illness, a finding that
approached significance. This finding is supported by the research of Conner, Pinquart,
and Duberstein (2008) who found a positive association between women's scores on
measurements of depression and treatment participation defined by frequency and
duration of treatment hours, number of days in treatment, and completing at least 90 days
of treatment. Joe, Simpson, and Broome (1999) also found that greater treatment
readiness predicted greater treatment involvement. Specifically, the greater degree to
which subjects reported they were ready and willing to make changes in their current
lives, particularly related to their substance use, the more involved they were in treatment
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based on attendance and participation. It may be that, while in treatment, women with a
diagnosed mental illness are receiving appropriate pharmacological treatment for their
mental illness that they are not able to obtain or maintain while not in treatment. This
may influence them to stay in treatment longer than women without a diagnosed mental
illness who may, nonetheless, suffer from an undiagnosed and, consequently, untreated
mental illness. It may also be that women diagnosed with mental illness, due to their
additional challenge of having a documented mental illness in addition to a substancerelated illness, are treated more generously by program staff and given more allowance
for treatment failures and absences than women without mental illness. Furthermore, it
should be noted that the variable days in treatment counted the number of days between
admission and discharge rather than the number of days of attendance. There was no
available measure of how many days or activities the women attended while in treatment.
In addition, contrary to the hypothesis that women with dependent children and/or
mental illness would have fewer negative toxicology screens than women without
dependent children and/or no mental illness, there was no significant difference between
these groups on the percentage of negative toxicology screens found during treatment.
For this population, it may be that percentage of negative toxicology screens is not a
pertinent indicator of treatment success. For instance, some women may have been
successful in abstaining from their preferred drug of choice, but used other substances
during treatment; therefore, although they would have a positive toxicology panel screen,
they may not have used their drug of addiction. A qualitative review of the data revealed
that, while some women who identified alcohol or cocaine as their primary drug of
addition would not test positive for these substances during treatment, they would test
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positive for cannabis. It may be that their occasional use of a drug they found not to be
problematic, actually assisted in their ability to remain abstinent from their primary
problem drug. Furthermore, it was noted that even though some women had a high
percentage of positive toxicology screens, they were still classified as treatment
compliant or partially compliant by staff.
Based on the findings of Chander and McCaul (2003) and Graff et al. (2009), it
was further hypothesized that women with dependent children and/or mental illness
would have significantly less treatment compliance than women without children and/or
mental illness. No significant differences were found between these groups with the
exception of women with mental illness who, contrary to expectations, were significantly
more likely to be classified by the program staff as treatment compliant than women
without mental illness. Hser (1995) proposed that counselor characteristics have a more
significant impact on treatment outcome, especially in socially oriented programs
compared to medically oriented programs. Again, it is possible that the treatment
compliance of women with mental illness is judged more leniently by program staff than
women without mental illness. Although behavioral guidelines were provided for
classifying treatment compliance, staff were not only allowed, but encouraged to take
into consideration each client's unique abilities and challenges. Therefore, it is likely the
determination of treatment compliance was subjective and influenced more by staff
impressions rather than strict behavioral guidelines. It is interesting to note that Anglin
and Hser (1990) found some evidence that flexible policies, goals and philosophies
produce better results than inflexible programs.
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Limitations and Future Research
Conducting research in a clinical setting is a challenging task. Using archival data
collected by clinical staff adds an even more challenging aspect to this research. In
controlled research populations, subjects can be carefully screened and classified then
placed into specific predetermined categories and evaluators are trained to use objective
criteria and avoid bias; however, these factors, important in conducting valid and reliable
research, are not typically applied in clinical settings, especially community-based
settings where resources are limited and the population being served are likely to be in
particular need of assistance. Clearly, a particular challenge identified in this archival
research was the nature of the original data collection. There was no systematic process
for ensuring that the same criteria for admittance, diagnosis, evaluation, classification,
and qualification of clients was used consistently for all clients. In fact, although the
researchers were told that several well-established assessments had been completed on a
large portion of the clients, including the Addiction Severity Index (ASI), the University
of Rhode Island Change Assessment (URIC A) and the Minnesota Family Investment
Program Self-Screen (MFIP), very few of these completed forms were found in clients'
charts. The amount of missing data is also a testament to the lack of rigor that was
applied to information gathering and recording. In addition, a fair amount of missing
data were due to data discrepancies found in the medical records. There were several
iterations of intake forms in the charts, necessitating a formulation of an artificial "intake
template" that was created in an effort to obtain the same information from the many
different locations it could be found in different charts.
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Another challenge presented in this research is that by the very nature of the
admittance criteria for this program, this population of women had moderate to severe
biopsychosocial problems. This is therefore a sample of the some of the most
challenging clients to engage and maintain in treatment due to their overwhelming lack of
resources, history of want, and number of obstacles to successful treatment. Just as
Greenfield and colleagues (2007) noted in their review of the literature on substance
abuse treatment entry, retention and outcome, these women had multiple problems
compounding their substance abuse problem. For example, although their average annual
income was $2,300, well below the poverty level, the mode of their income was zero.
Specifically, 119 women (54%) reported having no income. In fact, 97% of the sample
reported incomes below the 2004 poverty level of $9,310 established by the Department
of Health and Human Services (2004). Furthermore, 14% were homeless at the time of
their entry into treatment, forty-two percent had less than a high school degree, and
seventy-five percent had been arrested at least once.
Brady and Ashley (2005) reported that 46% of women in outpatient
nonmethadone programs completed treatment and average length of time in program was
154 days. In contrast, 27% of women in the present study were rated as treatment
compliant and the average length of treatment was 111 days. These figures may indicate
that the present sample had even more challenges and barriers to treatment than the
average women seeking substance abuse treatment.
In addition, the criteria for compliance and non-compliance were qualitative and
somewhat subjective. Although the CSB provided written guidelines for use in
determining degree of program compliance at discharge, as noted earlier in this paper, the
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criteria were, in actuality, used more as general guidelines rather than strictly adhered to
criteria. Although this was done in an attempt to take into consideration each client's
particular challenges and limitations, it does not lend itself to valid and reliable statistical
evaluation as the individual staff making the decision becomes a primary variable in the
outcome. In short, this was quite a subjective variable influenced by the staff that made
the decision.
Furthermore, the level of education, experience, and training of the persons
conducting intakes, classifying clients, and recording information varied greatly. In fact,
a CSB program director recognized the need for staff to be better trained in making
psychological diagnoses based on the DSM-IV. This lack of specialized training makes
the diagnoses used in this study somewhat suspect. As noted by Chander and McCaul
(2003) careful screening and assessment of alcohol use, drug use and psychiatrics
disorders is very important for planning appropriate treatment strategies for women.
There is a need for a better-organized and universal system of gathering data in
community settings in order to make these data suitable for statistical analysis and
generalization to larger populations. Persons who conduct intake interviews need
specialized training in conducting clinical interviews, recording data, and making DSMbased diagnoses. Researchers hoping to use archival data collected from clinical settings
need to be aware of the limitations imposed by the manner of original data collection and
establish realistic goals, accordingly. In addition, future research that uses negative
toxicology screens as an indicator of treatment success may need to look at abstinence
from specific drug of choice rather than abstinence from any substance on the toxicology
screen. Furthermore, it may be of benefit to use two standards for assessment treatment
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success: one that is based on measurable objective guidelines and another that takes into
consideration each individual's unique abilities and challenges.
It should be noted that the effect sizes and power for all analyses performed in
this study were extremely low. Similar to the aforementioned observation that
quantitative studies with larger samples sizes found the presence of dependent children to
be detrimental to treatment, while smaller qualitative studies reported dependent children
as a possible asset to treatment, the current study may have yielded significantly different
results had the sample size been larger and some of the data more objective and
quantifiable (e.g., compliance data). The effect sizes were likely too small to detect
significant differences that may have been found with a larger sample size. It may be that
in order to generalize findings from archival data in clinical settings, more programs must
be included. Combining data from numerous sites would increase the power of the
analyses and may yield more reliable results that can be used to improve services.
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SUMMARY AND CONCLUSIONS
There are little data on the impact of mental illness and dependent children on
women's substance abuse treatment outcomes. And among the few studies that have
looked at this very important issue there is no consensus on the impact of mental illness
and dependent children on treatment entry and outcome. Teasing out protective and risk
factors is a difficult task, further complicated by the "real life" aspect of conducting
research in clinical settings where decisions and resources are driven more by need and
finances than principles of conducting research. It is still unclear what impact dependent
children have on women's substance abuse treatment. It may be that the impact is highly
affected by the unique characteristics of each individual mother who seeks treatment for
her addiction and/or her mental illness. Due to the overwhelming number of variables
that impact treatment engagement, retention, and success for substance-abusing women,
it is difficult to tease out the degree and direction of impact of many variables on
treatment success. However, this is difficult in many current clinical settings, where the
focus is on helping women with the numerous challenges they face in addition to their
substance abuse; and where treatment resources and practices are highly influenced by
finances and policy-makers who may not have much experience with direct clinical
services or be able to keep up with the latest research.
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